-+ 0.00%
-+ 0.00%
-+ 0.00%

Ipsen Raises FY26 Sales Growth Outlook

MT Newswires·07/30/2026 01:31:16
Listen to the news
01:31 AM EDT, 07/30/2026 (MT Newswires) -- Ipsen (IPN.PA) on Thursday revised its full-year 2026 outlook with its latest earnings. The biopharmaceutical company now expects total sales growth of more than 20% at constant currency, up from its previous estimate of over 13%.